Prosecution Insights
Last updated: April 19, 2026
Application No. 17/595,672

CaCO3 COATED WITH MALEIC ANHYDRIDE GRAFTED POLYETHYLENE AND/OR MALEIC ANHYDRIDE GRAFTED POLYPROPYLENE AND AT LEAST ONE HYDROPHOBIZING AGENT

Final Rejection §103
Filed
Nov 22, 2021
Examiner
SASTRI, SATYA B
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Omya International AG
OA Round
4 (Final)
63%
Grant Probability
Moderate
5-6
OA Rounds
3y 1m
To Grant
93%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allow Rate
561 granted / 888 resolved
-1.8% vs TC avg
Strong +30% interview lift
Without
With
+29.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
63 currently pending
Career history
951
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
47.2%
+7.2% vs TC avg
§102
13.3%
-26.7% vs TC avg
§112
24.8%
-15.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 888 resolved cases

Office Action

§103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Per amendment dated 8/26/25, claims 1, 3-12, 15-19, 22, 24-26 are currently pending in the application, with claims 11, 12, 15-19 being withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 3-10, 22, 24-26 are rejected under 35 U.S.C. 103 as being unpatentable over Raper et al. (US 2013/0000518 A1), in view of Rentsch et al. (US 20150240056 A1) (references of record). Regarding claims 1, 3, 22, 24-26, Raper teaches a paint composition comprising a mineral treated with a hydrophobizing agent (Ab.). Disclosed mineral may be calcium carbonate in ground/powdered form, such as from marble, limestone, dolomite, chalk etc. (read on a)) [0034]. Disclosed genus of hydrophobizing agents include maleic anhydride grafted polyethylene and maleic anhydride grafted polypropylene (read on b), component i.), fatty acids, such as aliphatic carboxylic acids having 10 to 30 carbon atoms and mixtures thereof (read on carboxylic acids), fatty acid amides, metal/ammonium stearate etc. (read on reaction products), said hydrophobizing agent being used in an amount of 0.1 to 10 wt.% of the mineral (Ab., [0008], [0028]-[0031], [0034], [0046]-[0047]). Raper is silent on a calcium carbonate having claimed d98, comprising a treatment layer comprising a maleic anhydride grafted polyethylene/polypropylene polymer and a hydrophobizing agent as claimed, and having claimed properties. As the outset, it is noted that when the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. MPEP § 2144.05. In a related field of endeavor, Rentcsh teaches the use of mono-substituted succinic anhydride or a reaction product thereof, for use in surface-treated calcium carbonate filler for plastics, paints, adhesives etc. (Ab., [0046]-[0047], [0077]-[0078], ref. claims). Disclosed mono-substituted succinic anhydride include alkyl/alkenyl succinic anhydrides [0105]-[0150], and disclosed surface treated filler material has a d98 <15mm [0059]. Rentsch further prescribes an amount of 0.1 to 3 wt.% of mono-substituted succinic anhydride [0042], [0064], and teaches such surface treated filler as advantageously having low moisture pick up susceptibility, high volatile onset temperature, and a limited quantity of total volatiles evolved at temperatures of between 25 and 350°C [0033]. In view of the advantages taught in Rentsch, it would have been obvious to one of ordinary skill in the art, as of the effective filing date of the claimed invention, to provide for a surface treated calcium carbonate having a d98 within the claimed range, and comprising a treatment layer comprising 0.1 to 10 wt.% of a maleic anhydride grafted polyethylene/ polypropylene, and 0.1 to 3 wt.% a mono-alkyl/alkenyl substituted succinic anhydride, based on the wt. of the filler, including in an amount within the claimed wt.% range and weight ratio range (referred to as Rejection 1 herein below). In the alternative, Raper teaches as hydrophobizing agents, maleic anhydride grafted polyethylene/polypropylene, fatty acids, such as aliphatic carboxylic acids having 10 to 30 carbon atoms (read on carboxylic acids), fatty acid amides, metal/ammonium stearate (read on reaction products) etc., and mixtures thereof, i.e., equivalence thereof. Given the teaching in Rentsch on advantages of calcium carbonates of disclosed d98 and treated with mono-substituted succinic anhydrides, and the teaching in Raper on suitable hydrophobizing agents, it would have been obvious to one of ordinary skill in the art, as of the effective filing date of the claimed invention, to provide for a surface treated calcium carbonate having a d98 within the claimed range, comprising a treatment layer comprising 0.1 to 10 wt.% of a combination of maleic anhydride grafted polyethylene/polypropylene and a fatty acid/recation products/mixtures, based on their art recognized equivalence, and 0.1 to 3 wt.% of Rentsch’s mono-alkyl/alkenyl substituted succinic anhydride, based on the wt. of the filler, including in an amount within the claimed wt.% range and weight ratio range. It is prima facie obvious to combine equivalent materials when the equivalence is recognized by the prior art. See MPEP 2144.06. (referred to as Rejection 2 herein below). Additionally, given that surface treated calcium carbonate resulting from the modification of Raper’s filler with mono-substituted succinic anhydrides may provide for the same components in amounts as in the claimed invention, a skilled artisan would reasonably expect the treated calcium carbonates of overlapping scope to provide for the claimed moisture pick-up susceptibility and basic flowability, absent evidence to the contrary. As a practical matter, the Patent Office is not equipped to manufacture products by the myriad of processes put before it and then obtain prior art products and make physical comparisons. In re Brown, 459 F.2d 531, 535, 173 USPQ 685, 688 (CCPA 1972). With regard to claims 4-6, relying on Rejection 1, Raper’s maleic anhydride grafted polyethylene/polypropylene, in combination with Renstch’s mono-substituted succinic anhydride obviates the claimed components of the treatment layer. It is noted that claim 6 does not necessarily limit the scope of claim 3. Relying on alternative Rejection 2, Raper’s maleic anhydride grafted polyethylene/polypropylene and fatty acid/reaction products/mixture, in combination with Renstch’s mono-substituted succinic anhydride obviates the claimed components of the treatment layer. With regard to claims 7, 10, Raper and Renstch teach calcium carbonate in ground/powdered form, such as from marble, limestone, dolomite, chalk etc. (Raper- [0034], Renstch- [0090]-[0091]). With regard to claim 8, Renstch teaches calcium carbonate filler particles having properties within the claimed ranges as providing for the disclosed advantages [0033]-[0043]. With regard to claim 9, Raper teaches maleic anhydride grafted polypropylene and maleic anhydride grafted polyethylene, i.e., open to any type of polyethylene and polypropylene, including those within the scope of the claimed invention, absent evidence of criticality for the claimed species. Moreover, given that no comonomers are taught as being essential in the polypropylene chain, it would have been obvious to a skilled artisan to include a polypropylene homopolymer, which would be one of syndiotactic, atactic or isotactic type as in the claimed invention. Response to Arguments In view of the amendment dated 8/26/25, all rejections set forth in the nonfinal office action dated 5/27/25 are withdrawn and new grounds of rejections are presented herein above, relying on Raper-Rentsch combination. Applicant’s arguments and the Affidavit dated 8/26/25 have been duly considered. Applicants argue that the data in Table 4 demonstrates non-equivalence of MA-g-PE/PP and fatty acid. Referring to the data in Table 4, Applicants note that MB-1 comprising Powder 1 (1:1 palmitic acid and stearic acid, 1 part) has poor mechanical properties and good workability, whereas MB-3 comprising Powder 3 (maleic anhydride grafted PE, 2 parts) has poor workability and good mechanical properties. Applicants conclude that Raper’s fatty acids and maleic anhydride grafted PE are not equivalent alternatives. In response, as an initial matter, Rejection 1 above relies on selecting only Raper’s maleic anhydride grafted polyethylene/polypropylene as the hydrophobizing agent, in combination with Rentsch’s mono-substituted succinic anhydride. This combination does not rely on the equivalency argument. However, the alternative Rejection 2 relies on the Raper’s maleic anhydride grafted polyethylene/polypropylene and fatty acids/reaction products/mixtures, as being equivalent. Referring to the data in Table 1 of the specification and Table 4 of the Declaration, it is noted that Powder 1 (1 part) provides for different properties when compared to Powder 3 (2 parts). Thus, the comparison of properties of Powder 1 against Powder 3 is not proper back-to-back comparison given that the amounts and the type of the additive are varied simultaneously. Even so, this comparison may only establish that a 1:1 mixture of palmitic acid and stearic acid is not equivalent to a maleic anhydride-grafted PE that is involved in the example, and not the non-equivalence of the overlapping hydrophobizing agents that read on claimed b) ii. Applicants argue that claim 1 is non-obvious over Raper- Rentsch combination, and that the combination of hydrophobizing agent and maleic anhydride grafted polyethylene/polypropylene provides for unexpected results. Referring to MB-6 comprising a treated filler (powder 5) comprising a MA-g-PE/PP and hydrophobizing agent, Applicants note that it has good mechanical properties and workability, when compared to MB-3, comprising only MA-g-PE/PP. Applicants further note that a selection of a combination of succinic anhydrides and carboxylic acids provides for Powders 4 and 5 with significant improvements in properties, when compared to MB-3 comprising only MA-g-PE/PP. Applicants conclude that claim 1 is non-obvious over Raper and Rentsch. Referring to data in Table 5, Applicants argue that the mechanical properties in MB-5-MB7 are not negatively impacted compared to MB-3. In response, it is noted that Powder 3 for MB-3 (comparative) relies of MA-grafted PE3 (2 parts by wt./100 parts by wt. of CaCO3), while Powders 4 and 5 comprise a fatty acid mixture (1:1 palmitic acid and stearic acid, 0.5 part) and MA-grafted PE3 ((2.0 parts), i.e., the amount and the type of additive are varied simultaneously, precluding a proper back-to-back comparison. However, this data on superior workability and mechanical properties obtainable from Powders 4 and 5 or the mechanical properties of MB-5 to MB-7 are representative of a treated filler of limited scope. More importantly, the rejections herein above rely on mono-substituted succinic anhydride, alone or a combination of mono-substituted succinic anhydride with fatty acids/reaction products/mixtures. Applicants argue that the exemplified hydrophobizing agents are representative of the claimed hydrophobizing succinic anhydrides and carboxylic acids, because the claimed agents require the acid groups therein to be balanced by a nonpolar group. In response, it is noted that in Rejection 2 above, a mixture of mono-substituted succinic anhydride(s), in combination with one or more of Raper’s fatty acids/reaction products/mixtures is relied upon as hydrophobizing agent while in Rejection 1 above, Rentsch’s mono-substituted succinic anhydride alone is relied upon as the hydrophobizing agent. Given that Rentsch teaches as wide variety of mono-substituted succinic anhydrides [0109]-[0130], it is not clear why the specific species of succinic anhydride (ASA of Powder 6) would be considered reasonably representative of the recitation “succinic anhydrides or reaction products thereof”. In light of above, Examiner maintains that the data on record is not reasonably commensurate in scope with the claim language to overcome the applied art. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Satya Sastri at (571) 272 1112. The examiner can be reached Monday-Friday, 9AM-5.30PM (EST). If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Mr. Robert Jones can be reached at (571)-270- 7733. The fax phone number for the organization where this application or proceeding is assigned is (571) 273 8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll- free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272- 1000. /Satya B Sastri/ Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Nov 22, 2021
Application Filed
Jul 12, 2024
Non-Final Rejection — §103
Oct 04, 2024
Applicant Interview (Telephonic)
Oct 07, 2024
Examiner Interview Summary
Oct 14, 2024
Response Filed
Nov 19, 2024
Final Rejection — §103
Feb 20, 2025
Request for Continued Examination
Feb 21, 2025
Response after Non-Final Action
May 24, 2025
Non-Final Rejection — §103
Aug 26, 2025
Response Filed
Aug 26, 2025
Response after Non-Final Action
Nov 14, 2025
Final Rejection — §103
Jan 29, 2026
Applicant Interview (Telephonic)
Jan 29, 2026
Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12590183
POLYALKYLENEIMINE-BASED POLYMERS CONTAINING POLYETHER CHAINS
2y 5m to grant Granted Mar 31, 2026
Patent 12584015
POLYIMIDE RESIN COMPOSITION
2y 5m to grant Granted Mar 24, 2026
Patent 12583958
PHOTOPOLYMER FOR ANTI-YELLOWING AND ANTI-THERMAL CRACKING APPLICATIONS
2y 5m to grant Granted Mar 24, 2026
Patent 12577408
WATER-BASED COATING COMPOSITION, AND MULTI-LAYER COATING FILM
2y 5m to grant Granted Mar 17, 2026
Patent 12577341
Copolymer Derived From Substituted Benzopinacol And Use Of The Same As Polymerization Initiator
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
63%
Grant Probability
93%
With Interview (+29.5%)
3y 1m
Median Time to Grant
High
PTA Risk
Based on 888 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month